MoneyWorks4Me

Bharat Parenterals - Quaterly Results

09 Aug 2023 Evaluate
The total revenue stands at Rs. 699.10 millions for the June 2023 quarter. The mentioned figure indicates an increase of about 167.96% as against Rs. 260.90 millions during  the year-ago period.Net Profit for the quarter ended June 2023 zoomed to 611.20% from Rs. 12.50 millions to Rs. 88.90  millions.Operating profit for the quarter ended June 2023 rose to 143.50 millions as compared to 34.70 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 699.10 260.90 167.96 699.10 260.90 167.96 2179.80 2120.10 2.82
Other Income 28.60 15.40 85.71 28.60 15.40 85.71 188.40 77.80 142.16
PBIDT 143.50 34.70 313.54 143.50 34.70 313.54 402.10 360.00 11.69
Interest 8.80 2.50 252.00 8.80 2.50 252.00 21.90 9.70 125.77
PBDT 134.70 32.20 318.32 134.70 32.20 318.32 380.20 350.30 8.54
Depreciation 15.10 15.40 -1.95 15.10 15.40 -1.95 58.50 66.60 -12.16
PBT 119.60 16.80 611.90 119.60 16.80 611.90 321.70 283.70 13.39
TAX 30.70 4.30 613.95 30.70 4.30 613.95 78.30 70.70 10.75
Deferred Tax -1.40 -0.60 133.33 -1.40 -0.60 133.33 -5.70 -9.40 -39.36
PAT 88.90 12.50 611.20 88.90 12.50 611.20 243.40 213.00 14.27
Equity 57.70 57.70 0.00 57.70 57.70 0.00 57.70 57.70 0.00
PBIDTM(%) 20.53 13.30 54.33 20.53 13.30 54.33 18.45 16.98 8.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..